Research Article

Phenotypic Variation in Patients with Chronic Obstructive Pulmonary Disease in Primary Care

Table 2

Characteristics of all 438 patients with COPD treated in primary care.

CharacteristicAll patients
()
Treated by GP only
()
Treated by GP and PT for COPD
()
value

Sex, male (%)235 (54)166 (52)45 (58)0.71
Age (yr), mean (SD)69 (11)69 (11)69 (11)0.29
Physical activity (0–8), mean (SD)2.38 (2.31)2.20 (2.33)2.92 (1.99)0.001
Smoking (pack years), mean (SD)31.14 (23.54)30.45 (23.30)38.27 (22.32)0.004
GOLD stage, (%)<0.0001
 I141 (32)133 (55) 5 (7)
 II116 (27)88 (36)27 (41)
 III35 (8)14 (6)21 (32)
 IV20 (5)7 (3)13 (20)
Comorbidity, (%)
Cardiovascular116 (27)88 (26)25 (32)0.171
 Cardiac82 (19)61 (19)16 (21)0.440
 Vascular38 (9)22 (7)13 (17)0.009
 Stroke20 (5)14 (4)6 (8)0.177
Respiratory (asthma)56 (13)44 (14)9 (12)0.381
Psychological (depression)60 (14)44 (14)10 (13)0.499
Metabolic (diabetes)70 (16)50 (16)13 (17)0.469
Nutritional115 (27)87 (28)23 (30)0.390
Exacerbations in the past year, (%)<0.0001
 0204 (51)181 (57) 22 (28)
 1; of which hospitalised89 (22); 12 (13)70 (22); 8 (11)18 (23); 4 (22)
 2; of which hospitalised47 (12); 4 (9)32 (10); 3 (9)14 (18); 1 (8)
 3; of which hospitalised19 (5); 6 (32)14 (5); 5 (36)5 (7); 1 (20)
 more than 3; of which hospitalised39 (10); 21 (54)19 (6); 11 (58)19 (24); 10 (53)
Disease-related health status (0–6), mean (SD)
 Total CCQ1.51 (1.06)1.32 (0.97)2.19 (1.01)<0.0001
 Symptoms subscale1.95 (1.19)1.76 (1.14)2.49 (1.13)<0.0001
 Functional state subscale1.52 (1.28)1.20 (1.13)2.48 (1.29)<0.0001
 Mental state subscale0.75 (1.06)0.67 (1.00) 1.02 (1.13)0.004
General health perception (0–5), (%)<0.0001
 1, excellent6 (2)4 (1)1 (1)
 2, very good13 (3)11 (4)0
 3, good168 (42)133 (47)15 (20)
 4, moderate172 (44)112 (39)51 (66)
 5, poor37 (9)26 (9)10 (13)

GP: general practitioner; PT: physical therapist; SD: standard deviation; physical activity: rating from 0 “not physically active” to 8 “very physically active”; GOLD: the Global Initiative for Chronic Obstructive Lung Disease; GOLD stages: I: mild COPD, FEV1/FVC < 0.7, and FEV1 ≥ 80% of predicted; II: moderate COPD, FEV1/FVC < 0.7, and 50% ≤ FEV1 < 80% of predicted; III: severe COPD, FEV1/FVC < 0.7, and 30% ≤ FEV1 < 50% of predicted; IV: very severe COPD, FEV1/FVC < 0.7, and FEV1 < 30% of predicted or FEV1 < 50% of predicted plus chronic respiratory failure; FVC: postbronchodilator forced vital capacity; FEV1: postbronchodilator forced expiratory volume in one second; CCQ: Clinical COPD Questionnaire: rating from 0 “good” to 6 “bad.”